Emma Hall, Professor of Oncology Trials, is Co-Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), London, UK. She is a chartered statistician with over 20 years’ experience in the design, methodology and analysis of oncology clinical trials. She leads the ICR-CTSU’s portfolio of research in genitourinary and head and neck cancers with focus on the design and analysis of radiotherapy clinical trials. She is a previous co-chair of the National Clinical Research Institute (NCRI)’s Clinical and Translational Radiotherapy Research Group (CTRad) workstream on Phase 3 Trials and Methodology and now chairs their Working Group on impact and radiotherapy practice. She led the Cancer Research UK funded Advanced Radiotherapy Network’s methodology workstream, sits on CTRad’s Proton Beam Clinical Trial Strategy Group and the National Radiotherapy Trials Quality Assurance Management Group. She is an honorary member of the Royal College of Radiologists, an affiliate ESTRO member and a member of the Society for Clinical Trials. Professor Hall is a member of the Marie Curie Research Funding Committee, the Yorkshire Cancer Research Advisory Panel and vice chair of Cancer Research UK’s Clinical Research Monitoring Committee. She sits on the independent data monitoring and trial steering committees for a number of international and national clinical trials.